1. BASELINE CLINICAL AND PET‐CT TUMOR BURDEN PARAMETERS DO NOT PREDICT OUTCOME OF RELAPSE/REFRACTORY AGGRESSIVE B CELL LYMPHOMA PATIENTS TREATED WITH ANTI‐CD19 CAR T‐CELLS. (12th June 2019) Authors: Avigdor, A.; Davidson, T.; Shimoni, A.; Yerushalmi, R.; Shem‐Tov, N.; Danylesko, I.; Itzhaki, O.; Toren, A.; Jacoby, E.; Besser, M.; Nagler, A. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA. (23rd June 2022) Authors: Fried, S.; Besser, M. J.; Shkury, E.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Jacoby, E.; Itzhaki, O.; Shouval, R.; Kedmi, M.; Shimoni, A.; Nagler, A.; Avigdor, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 998 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE. (23rd June 2022) Authors: Shimoni, A.; Peczynski, C.; Labopin, M.; Angelucci, E.; Koc, Y.; Arat, M.; Tischer, J.; Sica, S.; Gülbas, Z.; Socié, G.; Blaise, D.; Pioltelli, P.; Ozdogu, H.; Vydra, J.; Ciceri, F.; Nagler, A.; Mohty, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PB1809: CLINICAL TRAJECTORY OF LONG-TERM SURVIVORS OF ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE INDUCTION CHEMOTHERAPY. (23rd June 2022) Authors: Heering, G.; Sasson, M.; Dominissini, D.; Shimoni, A.; Avigdor, A.; Nagler, A.; Canaani, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗